Back to Search

AKASH OZA, MD

MD

Internal Medicine Physician

NPI: 1336898170IndividualAccepts Medicare

Specialties, Licenses & Credentials

Internal Medicine PhysicianPrimary

Internal Medicine

Code: 207R00000X

1022945(MA)

CMS Specialties

PrimaryINTERNAL MEDICINE

Education

UNIVERSITY OF TENNESSEE, HSC, COLLEGE OF MEDICINE

Class of 2022

Research & Publications (20)

Phase II study of erlotinib in recurrent or metastatic endometrial cancer: NCIC IND-148.
PMID 18591547·J Clin Oncol·2008
3-trial
Stiffness of occipital-cervical constructs: beam theory.
PMID 18091247·Neurosurgery·2007
8-other
Granulocyte-colony-stimulating factor-mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage.
PMID 16398726·Transfusion·2006
4-observational
Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116).
PMID 12694666·Gynecol Oncol·2003
3-trial
Clinical development of P glycoprotein modulators in oncology.
PMID 11990771·Novartis Found Symp·2002
6-review
Phase I study of MG98, an oligonucleotide antisense inhibitor of human DNA methyltransferase 1, given as a 7-day infusion in patients with advanced solid tumors.
PMID 19383817·Clin Cancer Res·2009
3-trial
Bortezomib administered pre-auto-SCT and as maintenance therapy post transplant for multiple myeloma: a single institution phase II study.
PMID 19029964·Bone Marrow Transplant·2009
3-trial
Single-agent trabectedin as second-line therapy of persistent or recurrent endometrial cancer: results of a multicenter phase II study.
PMID 19476988·Gynecol Oncol·2009
3-trial
Evaluation of an intraperitoneal chemotherapy program implemented at the Princess Margaret Hospital for patients with epithelial ovarian carcinoma.
PMID 19135709·Gynecol Oncol·2009
3-trial
Efficacy of pegylated liposomal doxorubicin (PLD) plus carboplatin in ovarian cancer patients who recur within six to twelve months: a phase II study.
PMID 19520420·Gynecol Oncol·2009
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
801 MASSACHUSETTS AVENUE, CROSSTOWN 2
BOSTON, MA 02118

Quick Facts

NPI
1336898170
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
4
Publications
20

Are you this provider?

Claim Your Profile